A 59-year-old with COPD, FEV1 42% predicted, chronic bronchitis phenotype, frequent exacerbations despite triple therapy and low eosinophils asks abou...

Question

A 59-year-old with COPD, FEV1 42% predicted, chronic bronchitis phenotype, frequent exacerbations despite triple therapy and low eosinophils asks about additional therapies. Which is supported?

Accepted Answer

Roflumilast

Answer

Montelukast

Answer

Chronic prednisone 10 mg

Answer

Ipratropium monotherapy

Answer

No further options

us-abfm MCQ (SBA): COPD (Chronic Bronchitis)

A 59-year-old with COPD, FEV1 42% predicted, chronic bronchitis phenotype, frequent exacerbations despite triple therapy and low eosinophils asks about additional therapies. Which is supported?